BioCentury
ARTICLE | Distillery Therapeutics

Cancer

September 11, 2017 7:31 PM UTC

Mouse studies suggest inhibiting NELFB could help treat BRCA1-deficient breast cancer. In a mouse model of BRCA1 knockout-induced breast cancer, co-knockout of NELFB increased the number of tumor-free...